Obniska Jolanta, Lesyk Roman, Atamanyuk Dymytro, Kamiński Krzysztof
Department of Pharmaceutical Chemistry, Medical College of the Jagiellonian University, 9 Medyczna Str., 30-688 Kraków, Poland.
Acta Pol Pharm. 2005 May-Jun;62(3):213-9.
As part of our study, a series of N-phenyl- and N-benzyl-bicyclo [2.2.1] hept-5-ene-2,3-dicarboximides [III-XVI], structurally related to the previously described N-phenyl- or N-pirydyl-3-arylpyrrolidine-2,5-dione [I, II], were synthesized and tested for their anticonvulsant activity in the maximum electroshock seizure (MES) and metrazole seizure threshold (sc. MET) tests. The most potent in the maximum electroshock seizure (MES) test were compounds with methyl [III] and chloro [XI] substituents at position -2 of the aromatic ring, whereas of all the synthesized compounds, only N-(2-methoxybenzyl)-bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide [XII] was active in the sc. MET. Compounds with substituents at position -3 or -4 of the aromatic ring were found to be less active [V, VI, XIII and XIV], or devoid of activity [VII, IX, XV and XVI]. In contrast, the N-(4-chlorophenyl)-bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide [VIII] at a dose of 100 mg/kg was active in the MES test.
作为我们研究的一部分,合成了一系列与先前描述的N-苯基-或N-吡啶基-3-芳基吡咯烷-2,5-二酮[I, II]结构相关的N-苯基-和N-苄基-双环[2.2.1]庚-5-烯-2,3-二甲酰亚胺[III-XVI],并在最大电休克惊厥(MES)和戊四氮惊厥阈值(即MET)试验中测试了它们的抗惊厥活性。在最大电休克惊厥(MES)试验中最有效的是在芳环-2位带有甲基[III]和氯[XI]取代基的化合物,而在所有合成化合物中,只有N-(2-甲氧基苄基)-双环[2.2.1]庚-5-烯-2,3-二甲酰亚胺[XII]在MET试验中有活性。发现在芳环-3位或-4位带有取代基的化合物活性较低[V, VI, XIII和XIV],或无活性[VII, IX, XV和XVI]。相比之下,N-(4-氯苯基)-双环[2.2.1]庚-5-烯-2,3-二甲酰亚胺[VIII]在100 mg/kg剂量下在MES试验中有活性。